![Aarthi Jayanthan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aarthi Jayanthan
Direttore operativo presso Phoenix Molecular Designs Ltd.
Posizioni attive di Aarthi Jayanthan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Direttore operativo | - | - |
Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Aarthi Jayanthan
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Aarthi Jayanthan
- Esperienza